Concepts (151)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| GABA Agents | 1 | 2018 | 26 | 0.640 |
Why?
|
| Valproic Acid | 1 | 2018 | 263 | 0.570 |
Why?
|
| Psychotic Disorders | 1 | 2018 | 147 | 0.570 |
Why?
|
| Carcinoid Tumor | 1 | 2018 | 280 | 0.540 |
Why?
|
| Empathy | 1 | 2016 | 101 | 0.530 |
Why?
|
| Heart Neoplasms | 1 | 2018 | 214 | 0.530 |
Why?
|
| Depression | 5 | 2021 | 1715 | 0.510 |
Why?
|
| Oncologists | 1 | 2016 | 134 | 0.490 |
Why?
|
| Pastoral Care | 2 | 2012 | 7 | 0.450 |
Why?
|
| Chaplaincy Service, Hospital | 1 | 2012 | 4 | 0.430 |
Why?
|
| Professional Role | 1 | 2012 | 78 | 0.400 |
Why?
|
| Hallucinations | 1 | 2010 | 35 | 0.380 |
Why?
|
| Meningeal Carcinomatosis | 1 | 2010 | 31 | 0.370 |
Why?
|
| Interdisciplinary Communication | 1 | 2012 | 280 | 0.360 |
Why?
|
| Vision Disorders | 1 | 2010 | 245 | 0.320 |
Why?
|
| Psychiatry | 1 | 2012 | 307 | 0.310 |
Why?
|
| Cognition Disorders | 3 | 2007 | 786 | 0.260 |
Why?
|
| Neoplasms | 7 | 2021 | 15193 | 0.260 |
Why?
|
| Mood Disorders | 1 | 2005 | 163 | 0.240 |
Why?
|
| Mental Disorders | 1 | 2012 | 862 | 0.240 |
Why?
|
| Antidepressive Agents | 2 | 2005 | 332 | 0.240 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2010 | 1039 | 0.240 |
Why?
|
| Interferons | 1 | 2005 | 291 | 0.240 |
Why?
|
| Delirium | 2 | 2016 | 207 | 0.230 |
Why?
|
| Postoperative Complications | 1 | 2018 | 5542 | 0.220 |
Why?
|
| Psycho-Oncology | 1 | 2021 | 6 | 0.210 |
Why?
|
| Anxiety | 4 | 2021 | 1179 | 0.190 |
Why?
|
| Stress, Psychological | 4 | 2013 | 1000 | 0.180 |
Why?
|
| Depressive Disorder, Major | 2 | 2017 | 441 | 0.180 |
Why?
|
| Symptom Assessment | 1 | 2021 | 267 | 0.170 |
Why?
|
| Emergency Service, Hospital | 3 | 2016 | 1148 | 0.170 |
Why?
|
| Pain Management | 1 | 2003 | 668 | 0.150 |
Why?
|
| Anxiety Disorders | 1 | 2021 | 666 | 0.130 |
Why?
|
| Depressive Disorder | 2 | 2017 | 557 | 0.130 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2017 | 901 | 0.120 |
Why?
|
| Fear | 2 | 2012 | 254 | 0.120 |
Why?
|
| Ovarian Neoplasms | 3 | 2017 | 4638 | 0.110 |
Why?
|
| Clergy | 1 | 2012 | 9 | 0.110 |
Why?
|
| Resuscitation Orders | 1 | 1992 | 68 | 0.110 |
Why?
|
| Religion and Medicine | 1 | 2012 | 50 | 0.100 |
Why?
|
| Common Bile Duct Neoplasms | 1 | 2012 | 145 | 0.100 |
Why?
|
| Ampulla of Vater | 1 | 2012 | 155 | 0.100 |
Why?
|
| Humans | 26 | 2021 | 261506 | 0.100 |
Why?
|
| Quetiapine Fumarate | 1 | 2010 | 16 | 0.100 |
Why?
|
| Dibenzothiazepines | 1 | 2010 | 13 | 0.100 |
Why?
|
| Interferon-alpha | 2 | 2004 | 889 | 0.100 |
Why?
|
| Spirituality | 1 | 2012 | 129 | 0.100 |
Why?
|
| Surveys and Questionnaires | 2 | 2021 | 5687 | 0.090 |
Why?
|
| Medical Oncology | 2 | 2019 | 1423 | 0.080 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2013 | 519 | 0.080 |
Why?
|
| Antipsychotic Agents | 2 | 2010 | 414 | 0.080 |
Why?
|
| Attitude to Death | 1 | 2009 | 100 | 0.080 |
Why?
|
| Fatal Outcome | 1 | 2010 | 829 | 0.080 |
Why?
|
| Pancreatectomy | 1 | 2012 | 652 | 0.080 |
Why?
|
| Hyperparathyroidism | 1 | 2007 | 93 | 0.070 |
Why?
|
| Syndrome | 1 | 2010 | 1351 | 0.070 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2016 | 1105 | 0.070 |
Why?
|
| Middle Aged | 12 | 2018 | 86204 | 0.070 |
Why?
|
| Survivors | 1 | 2012 | 1031 | 0.070 |
Why?
|
| Motivation | 1 | 2009 | 499 | 0.070 |
Why?
|
| Parathyroid Neoplasms | 1 | 2007 | 185 | 0.070 |
Why?
|
| Central Nervous System Stimulants | 1 | 2005 | 225 | 0.060 |
Why?
|
| Psychotherapeutic Processes | 1 | 2003 | 9 | 0.060 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 | 2004 | 2527 | 0.060 |
Why?
|
| Adenoma | 1 | 2007 | 716 | 0.050 |
Why?
|
| Comorbidity | 3 | 2016 | 2352 | 0.050 |
Why?
|
| Female | 13 | 2019 | 141928 | 0.050 |
Why?
|
| Drug Therapy, Combination | 2 | 2004 | 2315 | 0.050 |
Why?
|
| Tomography, Emission-Computed | 4 | 1996 | 310 | 0.050 |
Why?
|
| Retrospective Studies | 2 | 2021 | 37905 | 0.050 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 2195 | 0.050 |
Why?
|
| Treatment Outcome | 3 | 2018 | 32848 | 0.050 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2016 | 5437 | 0.040 |
Why?
|
| United States | 2 | 2013 | 15433 | 0.040 |
Why?
|
| Risk Factors | 3 | 2016 | 17523 | 0.040 |
Why?
|
| Prospective Studies | 4 | 2016 | 12873 | 0.040 |
Why?
|
| Social Support | 3 | 2009 | 560 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2012 | 10035 | 0.040 |
Why?
|
| Male | 9 | 2019 | 123000 | 0.030 |
Why?
|
| Marijuana Abuse | 1 | 1996 | 67 | 0.030 |
Why?
|
| Antisocial Personality Disorder | 1 | 1995 | 62 | 0.030 |
Why?
|
| Violence | 1 | 1995 | 116 | 0.030 |
Why?
|
| Pancreatic Neoplasms | 1 | 2012 | 5061 | 0.030 |
Why?
|
| Pain | 1 | 2003 | 1658 | 0.030 |
Why?
|
| Patient Isolation | 1 | 1994 | 25 | 0.030 |
Why?
|
| Adult | 10 | 2016 | 77950 | 0.030 |
Why?
|
| Aged, 80 and over | 4 | 2016 | 29902 | 0.030 |
Why?
|
| Aged | 6 | 2016 | 70117 | 0.030 |
Why?
|
| Affect | 1 | 1994 | 288 | 0.030 |
Why?
|
| Papillomaviridae | 1 | 2016 | 624 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 1995 | 621 | 0.030 |
Why?
|
| Cross-Sectional Studies | 2 | 2012 | 4314 | 0.020 |
Why?
|
| Blood Glucose | 1 | 1995 | 1244 | 0.020 |
Why?
|
| Young Adult | 3 | 2016 | 21445 | 0.020 |
Why?
|
| Brain | 2 | 1996 | 4113 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 1994 | 1581 | 0.020 |
Why?
|
| Patient Participation | 1 | 1992 | 446 | 0.020 |
Why?
|
| Heroin Dependence | 1 | 1988 | 54 | 0.020 |
Why?
|
| Cognition | 1 | 1994 | 968 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2016 | 3890 | 0.020 |
Why?
|
| Recurrence | 1 | 2016 | 4758 | 0.020 |
Why?
|
| Papillomavirus Infections | 1 | 2016 | 980 | 0.020 |
Why?
|
| Family Therapy | 1 | 2007 | 37 | 0.020 |
Why?
|
| Smoking | 1 | 2016 | 2440 | 0.020 |
Why?
|
| Religion | 1 | 2007 | 91 | 0.020 |
Why?
|
| Prognosis | 2 | 2016 | 21713 | 0.020 |
Why?
|
| Cocaine | 1 | 1988 | 233 | 0.020 |
Why?
|
| Parathyroidectomy | 1 | 2007 | 203 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 6207 | 0.020 |
Why?
|
| Quality of Life | 2 | 2010 | 4532 | 0.020 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 1988 | 223 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2004 | 2307 | 0.020 |
Why?
|
| Frontal Lobe | 2 | 1996 | 187 | 0.020 |
Why?
|
| Triage | 1 | 2007 | 252 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2013 | 4988 | 0.020 |
Why?
|
| Personality Disorders | 1 | 2007 | 164 | 0.020 |
Why?
|
| Brain Diseases | 1 | 1988 | 403 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 8865 | 0.010 |
Why?
|
| Behavior Therapy | 1 | 2007 | 298 | 0.010 |
Why?
|
| Counseling | 1 | 2007 | 381 | 0.010 |
Why?
|
| Substance-Related Disorders | 1 | 1988 | 524 | 0.010 |
Why?
|
| Neoadjuvant Therapy | 1 | 2016 | 4975 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2013 | 3719 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2013 | 2403 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2013 | 9180 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2004 | 980 | 0.010 |
Why?
|
| Mass Screening | 1 | 2009 | 1509 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2013 | 9244 | 0.010 |
Why?
|
| Age Factors | 1 | 2009 | 5377 | 0.010 |
Why?
|
| Survival Rate | 1 | 2012 | 12221 | 0.010 |
Why?
|
| Disease Progression | 1 | 2009 | 6682 | 0.010 |
Why?
|
| Palliative Care | 1 | 2009 | 2037 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 14889 | 0.010 |
Why?
|
| Paleopathology | 1 | 1996 | 2 | 0.010 |
Why?
|
| Psychomotor Disorders | 1 | 1996 | 32 | 0.010 |
Why?
|
| Dronabinol | 1 | 1996 | 35 | 0.010 |
Why?
|
| Basal Ganglia | 1 | 1996 | 64 | 0.010 |
Why?
|
| Deoxyglucose | 1 | 1995 | 115 | 0.010 |
Why?
|
| Environment, Controlled | 1 | 1994 | 21 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2009 | 13658 | 0.010 |
Why?
|
| Temporal Lobe | 1 | 1995 | 192 | 0.010 |
Why?
|
| Internal-External Control | 1 | 1994 | 110 | 0.010 |
Why?
|
| Reference Values | 1 | 1995 | 1099 | 0.010 |
Why?
|
| Psychological Tests | 1 | 1994 | 131 | 0.010 |
Why?
|
| Cerebellum | 1 | 1996 | 449 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1996 | 1819 | 0.010 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 1995 | 1226 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 1995 | 992 | 0.010 |
Why?
|
| Cerebrovascular Disorders | 1 | 1988 | 142 | 0.000 |
Why?
|
| Radiography | 1 | 1988 | 1904 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 2 | 1988 | 7702 | 0.000 |
Why?
|